erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
.
.
.
cutting luxuries could give savers extra ?10k in retirement
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
please keep our community civil. comments should remain on topic and be respectful.
.
.